Results 1 to 10 of about 11,598 (176)

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy [PDF]

open access: yesScientific Reports, 2022
Reversible conduction failure (RCF) has been documented in acute motor axonal neuropathy (AMAN) and is considered a sign of nodopathy. Several reports of RCF in acute inflammatory demyelinating polyneuropathy (AIDP) have suggested that it could be a ...
Sooyoung Kim   +2 more
doaj   +4 more sources

A young adult with leptospirosis associated acute inflammatory demyelinating polyneuropathy [PDF]

open access: yesSouthern African Journal of Infectious Diseases, 2023
Leptospirosis is a zoonotic disease that commonly affects the liver and kidney. It can rarely affect the neurological system with aseptic meningitis being the commonest neurological presentation.
Herman Bagula   +2 more
doaj   +4 more sources

Acute Inflammatory Demyelinating Polyneuropathy and a Unilateral Babinski/Plantar Reflex [PDF]

open access: yesAnesthesiology Research and Practice, 2008
Acquired acute demyelinating peripheral polyneuropathy (AADP) is a general classification of pathologies that could affect secondary the peripheral nervous system. They are characterized by an autoimmune process directed towards myelin.
Davide Cattano   +4 more
doaj   +10 more sources

Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19

open access: yesDüzce Tıp Fakültesi Dergisi, 2022
The cases of Guillain Barre Syndrome (GBS) have been reported following the coronavirus disease 2019 (COVID-19). Here, we describe a case that evolved from GBS to chronic inflammatory demyelinating polyneuropathy (CIDP) after COVID-19 in terms of ...
Nilgün Çınar   +4 more
doaj   +4 more sources

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy. [PDF]

open access: yesCureus, 2018
Pembrolizumab is a humanized monoclonal antibody that blocks the programmed cell death 1 (PD-1) pathway, thereby enhancing antitumor immunity. As the use of immune checkpoint inhibitors becomes more prevalent, so do immune-related adverse events associated with their use.
Manam R   +6 more
europepmc   +4 more sources

Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Masked by Autoimmune Thyroiditis [PDF]

open access: yesJ Endocr Soc, 2021
Abstract Hashimoto’s thyroiditis and Guillain-Barre syndrome (GBS) are autoimmune disorders that are both well-known in their own right. Hashimoto’s is one of the most common causes of primary hypothyroidism, and GBS involves immune mediated damage to the peripheral nervous system.
Wirtshafter S, Iqbal I.
europepmc   +3 more sources

Chronic inflammatory demyelinating polyneuropathy with an acute onset. Clinical case [PDF]

open access: yesТерапевтический архив, 2022
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous treatable dysimmune neuropathy. The variety of clinical forms and course of the disease can be challenging for proper diagnosis and early treatment.
Natalia A. Suponeva   +5 more
doaj   +3 more sources

Tubercular Meningitis with Acute Inflammatory Demyelinating Polyneuropathy-Trigger or Chance. [PDF]

open access: yesJ Neurosci Rural Pract, 2019
AbstractTuberculosis being a global pandemic causes an array of neurological presentations ranging from tuberculoma, meningitis, radiculomyelitis, brain abscess, and so on.Association of Guillain-Barre syndrome with tuberculosis has been reported five to six times in the past.
Dalai SP, Kabi S, Arve NR, Kakollu VR.
europepmc   +3 more sources

Acute sensory inflammatory demyelinating polyneuropathy and central diabetes insipidus

open access: yesНеврология, нейропсихиатрия, психосоматика, 2021
Guillain-Barre syndrome (GBS) is characterized by acute, progressive monophasic course with a predominance of motor disorders in typical cases; it develops due to an aberrant immune response in some viral and bacterial infections.
T. G. Sakovets, E. I. Bogdanov
doaj   +3 more sources

A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy. [PDF]

open access: yesEur J Neurol
AbstractBackground and purposeClinical symptoms and laboratory indices for acute inflammatory demyelinating polyneuropathy (AIDP), a variant of Guillain−Barré syndrome, and acute‐onset chronic inflammatory demyelinating polyneuropathy (A‐CIDP) were analyzed to identify factors that could contribute to early differential diagnosis.MethodsA retrospective
Zhang W   +5 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy